Polyphenol derivatives - Potential regulators of neutrophil activity

Interdisciplinary Toxicology

Volumn 5, Issue 2, 2012, Pages 65-70

  Drábiková, Katarína ^a   Perečko, Tomáš ^a   Nosál, Radomír ^a   Harmatha, Juraj ^b   Šmidrkal, Jan ^c   Jančinová, Viera ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

Activity of neutrophils; Natural polyphenols; Reactive oxygen species

Indexed keywords

CURCUMIN; FERULIC ACID; N FERULOYLSEROTONIN; PICEATANNOL; PINOSYLVIN; POLYPHENOL DERIVATIVE; PROTEIN KINASE C; PTEROSTILBENE; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

CELL ACTIVITY; CELL FREE SYSTEM; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; REVIEW; SIGNAL TRANSDUCTION;

EID: 84876541030     PISSN: 13376853     EISSN: 13379569     Source Type: Journal    
DOI: 10.2478/v10102-012-0011-8     Document Type: Review

References (41)

1. Aggarwal BB, Sung B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30:85-94.
2. Ak T, Gülçin I. Antioxidant and radical scavenging properties of curcumin. (2008). Chemico-Biological Interactions 174:27-37.
3. Deby-Dupont G, Mouithys-Mickalad A, Serteyn D, Lamy M, Deby C. (2005). Resveratrol and curcumin reduce the respiratory burst of Chlamydiaprimed THP-1cells. Biochem Biophys Res Commun 333:21-27. (Pubitemid 40813441)
4. Drábiková K, Perečko T, Nosál R, Bauerová K, Poništ S, Mihalová D, Kogan G, Jančinová V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacol Res 59:399-403.
5. Fan GJ, Liu XD, Qian Y P, Shang YJ, Li XZ, Dai F, Fang JG, Jin XL, Zhou, B. (2009). 4, 4'-Dihydroxy-trans-stilbene, a resveratrol analogue, exhibited enhanced antioxidant activity and cytotoxicity. Bioorg Med Chem 17:2360-2365.
6. Fontayne A, Dang P M C, Gougerot-Pocidalo MA, El Benna J. (2002). Phosphorylation of p47phox sites by PKC a, β II, d and?: effect on binding to p22phox and on NADPH oxidase activation. Biochemistry 41:7743-7750. (Pubitemid 34627801)
7. Fraga CG, Galleano M, Verstraten S, Oteiza PI. (2010). Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Asp Med 31:435-445.
8. Franck T, Kohnene S, Grulke S, Neven, P, Goutman Y, Peters F, Pirotte B, Deby-Dupont G, Serteyn D. (2008). Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol Res 57:577-587.
9. Jančinová V, Drábiková K, Nosál R, Račková L, Májeková M, Holománová D. (2006). The combined luminol/isoluminol chemiluminescence method for differentiating between extracellular and intracellular oxidant production by neutrophils. Redox Rep 1:110-116. (Pubitemid 44111106)
10. Jančinová V, Perečko T, Nosál R, Koštálová D, Bauerová K, Drábiková K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol 612:161-166.
11. Jančinová V, Perečko T, Drábiková K, Nosál R, Sviteková K. (2011). Piceatannol, a natural analogue of resveratrol, inhibits oxidative burst of human neutrophils. Interdisciplinary Toxicol 4:A35-A36.
12. Karlsson A, Dahlgren C. (2002). Assembly and activation of the neutrophil NADPH oxidase in granule membranes. Antioxid Redox Signal 4:49-60. (Pubitemid 34260686)
13. Khlebnikov AI, Schepetkin I, Domina NG, Kirpotina LN, Quinn MT. (2007). Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic and cellular systems. Bioorg Med Chem 15:1749-1770. (Pubitemid 46394047)
14. Klink M, Jastrzembska K, Bednarska K, Banasik M, Sulowska Z. (2009). Efect of nitric oxide donors on NADPH oxidase signaling pathway in human neutrophils in vitro. Immunobiology 214:692-702.
15. Lee MR, Duan W, Tan SL. (2008). Protein kinase isoenzymes as potential targets in immune disorders. Expert Opin Ther Targets 12:535-552. (Pubitemid 351699475)
16. Lin HC, Tsai SH, Chen CS, Chang YC, Lee CM, Lai ZY, Lin CM. (2008). Structureactivity relationship of coumarin derivatives on xanthine oxidase-inhibiting and free radical-scavenging activities. Biochem Pharmacol 75:1416-1425.
17. Nosál R, Perečko T, Jančinová V, Drábiková K, Harmatha J, Sviteková K. (2010). Suppression of oxidative burst in human neutrophils with the naturally occurring serotonin derivative isomer from Leuzea carthamoides. Neuroendocrinol Lett 31:69-72.
18. Nosál R, Perečko T, Jančinová V, Drábiková K, Harmatha, J, Sviteková K. (2011). Naturally appearing N-feruloylserotonin isomers supress oxidative burst of human neutrophils at the protein kinase C level. Pharmacol Rep 63:790-798.
19. Obrenovich ME, Nair NG, Beyaz A, Aliev G, Reddy VP. (2010). The role of polyphenolic antioxidants in health, disease, and aging. Rejuvenation Res 13:631-664.
20. Pan Z, Agarwal AK, Xu T, Feng Q, Baerson SR, Duke SO, Rimando AM. (2008). Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med Genomics 1:1-13.
21. Pandey KB, Rizvi SI. (2009). Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2:270-278.
22. Perečko T, Jančinová V, Drábiková K, Nosál R, Harmatha J. (2008). Structure - effciency relationship in derivatives of stilbene. Comparison of resveratrol, pinosylvin and pterostilbene. Neuroendocrinol Lett 29:802-805.
23. Perečko T, Drábiková K, Račková L, Číž M, Podborská M, Lojek A., Harmatha J, Šmidrkal, J, Nosál R, Jančinová V. (2010). Molecular targets of the natural antioxidant pterostilbene: effect on protein kinase C, caspase-3 and apoptosis in human neutrophils in vitro. Neuroendocrinol Lett 31:84-90.
24. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. (2009). Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells. Br J Nut. 102:264-72.
25. Queiroz AN, Gomes B A Q, Moraes WM, Borges RS. (2009). A theoretical antioxidant pharmacophore for resveratrol. Eur J Med Chem 44:1644-1649.
26. Račková L, Drábiková K, Janč inová V, Perečko T, Šmidrkal J, Harmatha J, Tóth J, Koštálová D, Bezek Š, Štefek M, Nosál R. (2009). Structural apects of antioxidant action of selected natural polyphenols. Free Rad Res 4:S39.
27. Rahman I, Biswas SK, Kirkham PA. (2006). Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-1452. (Pubitemid 44666744)
28. Rahman I. (2008). Dietary polyphenols mediated regulation of oxidative stress and chromatin remodelling in inflammation. Nutrition Reviews 66:S42-S45.
29. Rizvi SI, Pandey KB. (2010). Activation of the erythrocyte plasma membrane redox system by resveratrol: a possible mechanism for antioxidant properties. Pharmacol Rep 62:726-732.
30. Rossi M, Caruso F, Opazo C, Salciccioli J. (2008). Crystal and molecular structure of piceatannol; scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin. J Agric Food Chem 26:10557-10566.
31. Roupe KA, Remsberg CM, Yañez JA, Davies NM. (2006). Pharmacometrics of stilbenes: seguing towards the clinic. Curr Clin Pharmacol 1:81-101.
32. Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ. (2003). Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta 1637:59-69. (Pubitemid 36071597)
33. Stevenson DE, Hurst RD. (2007). Plyphenolic phytochemicals-just antioxidants or much more? Cell Mol Life Sci 64:2900-2916. (Pubitemid 351152245)
34. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V. (2001). Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586-22594.
35. Stojanovič S, Sprinz H, Brede O. (2001). Effciency and mechanism of the antioxidant action of trans-Resveratrol and its analogues in the radical liposome oxidation. Arch Biochem Biophys 391:79-89. (Pubitemid 32612575)
36. Šmidrkal J, Harmatha J, Budešínský M, Vokáč K, Zídek Z, Kmoníčková E, Merkl R, Filip V. (2010). Modified approach for preparing (E)-stilbenes related to resveratrol, and evaluation of their potential immunobiological effects. Collect Czech Chem Commun 7:175-186.
37. Štefek M. (2011). Natural fiavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdisciplinary Toxicol 4:69-77.
38. Takahashi T, Miyazawa M. (2011). Synthesis and structure-activity relationships of phenylpropanoid amides of serotonin on tyrosinase inhibition. Bioorg Med Chem Lett 21:1983-1986.
39. Ursini F, Maiorino M, Morazzoni P, Roveri A, Pifferi G. (1994). A novel antioxidant flavonoid (ldB 1031) affecting molecular mechanisms of molecular activation. Free Radic Biol Med 16:547-553. (Pubitemid 24136600)
40. Varga Zs, Seres I, Nagy E, Ujhelyi L, Balla G, Balla J, Antus S. (2006). Structure prerequisite for antioxidant activity of silybin in different biochemical systems in vitro. Phytomedicine 13:85-93. (Pubitemid 41797595)
41. Wesolowska O, Kuzdzal, Štrancar J, Michalak K. (2009). Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes. Biochim Biophys Acta 1788:1851-1860.